Effects of different doses of atorvastatin on prevention of contrast-induced nephropathy after percutaneous coronary intervention in patients with elevated high-sensitivity C-reactive protein:a comparative study

Yong YANG,Jing YAO,Geng LIU,Yu-feng CHANG

DOI: https://doi.org/10.11675/j.issn.0253-4304.2018.01.18

2018-01-01

Abstract:Objective To compare the effects of different doses of atorvastatin on the prevention of contrast-induced nephropathy ( CIN) after percutaneous coronary intervention( PCI) in the patients with elevated high-sensitivity C-reactive protein( hs-CRP) . Methods Seventy-eight patients with coronary heart disease who underwent PCI were divided into study group(n=39) and control group(n=39) using the random number table method. The patients in the two groups were treated with atorvastatin at 24 hours before PCI and within 72 hours after operation. The control group was given a conventional dose of oral atorvastatin(20 mg/d),and the study group was given the intensive therapy with a high dose of atorvastatin(40 mg/d). The levels of hs-CRP,serum creatinine(SCr) and blood urea nitrogen(BUN) were compared between the two groups before operation and within 72 hours after operation,and the incidence rates of CIN and adverse cardiovascular events were counted in the two groups. Results The levels of hs-CRP and SCr increased and the level of BUN decreased in both groups after operation(all P<0. 05). After operation,the level of hs-CRP in the study group was lower than that in the control group (P<0. 05),but no significant difference was found in the SCr or BUN level between the two groups(P>0. 05). There was no significant difference in the incidence rate of CIN or adverse cardiovascular events between the two groups(P>0. 05). Conclusion Compared with the conventional dose therapy,the intensive therapy of atorvastatin can significantly reduce the level of hs-CRP after PCI in patients with elevated hs-CRP,but both of them have similar preventive effects on CIN.